Erserine en es it fr

Erserine Brand names, Erserine Analogs

Erserine Brand Names Mixture

  • No information avaliable

Erserine Chemical_Formula


Erserine RX_link

Erserine fda sheet

Erserine msds (material safety sheet)

Erserine Synthesis Reference

Zhang J,et al. Appl Microbiol Biotechnol. 44(5):568-75.

Erserine Molecular Weight

275.346 g/mol

Erserine Melting Point

105.5 oC

Erserine H2O Solubility

7760 mg/L

Erserine State


Erserine LogP


Erserine Dosage Forms


Erserine Indication

For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.

Erserine Pharmacology

Physostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission. Physostigmine is used to treat glaucoma. Because it crosses the blood-brain barrier, it is also used to treat the central nervous system effects of atropine overdose and other anticholinergic drug overdoses. Physostigmine can reverse both central and peripheral anticholinergia.

Erserine Absorption

No information avaliable

Erserine side effects and Toxicity

Side effects include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth, blurred vision or change in near or distant vision, and eye pain.

Erserine Patient Information

No information avaliable

Erserine Organisms Affected

Humans and other mammals